Tafamidis, CAS [[594839-88-0]]
Artikelnummer:
TGM-T4565
- Bilder (1)
| Artikelname: | Tafamidis, CAS [[594839-88-0]] |
| Artikelnummer: | TGM-T4565 |
| Hersteller Artikelnummer: | T4565 |
| Alternativnummer: | TGM-T4565-1MLX10MM(INDMSO),TGM-T4565-5MG,TGM-T4565-10MG,TGM-T4565-25MG,TGM-T4565-50MG,TGM-T4565-100MG |
| Hersteller: | TargetMol |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | Fx-1006A |
| Tafamidis (Fx-1006A) is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs. It binds to TTR with negative cooperativity (Kd1: 3 nM, Kd2: 278 nM) to stabilize the TTR dimer-dimer interface and inhibit tetrameric dissociation. Tafamidis stabilizes wild-type and clinically significant V30M and V122I mutant TTR amyloidogenic homotetramers (EC50s: 2.7-3.2 µM) under fibril-promoting, denaturing, and physiological conditions in vitro. It stabilizes TTR heterotetramers containing wild-type and mutant subunits ex vivo in human plasma derived from patients carrying V30M or V1221 mutations when used at a concentration of 7.2 µM. Formulations containing tafamidis have been used for the treatment of familial amyloid polyneuropathy. |
| Molekulargewicht: | 308.12 |
| Reinheit: | 0.9965 |
| CAS Nummer: | [594839-88-0] |
| Formel: | C14H7Cl2NO3 |
| Target-Kategorie: | Others |

